(Q33725862)

English

Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Taishin Akiyama

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hironori Adachi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jun-ichiro Inoue

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yoshikazu Nakamura

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Arthritis and Rheumatism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

455-466

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20967861%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

IL-17 and Th17 Cells

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Differentiation and function of pro-inflammatory Th17 cells

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

In vitro selection of RNA molecules that bind specific ligands

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Aptamers as candidate therapeutics for cardiovascular indications

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Neutrophilic airway inflammation and IL-17.

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Regulation of inflammatory responses by IL-17F

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Interleukin-17 is a negative regulator of established allergic asthma

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Unmet needs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

1 reference

https://api.crossref.org/works/10.1002%2FART.30108

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33725862&oldid=1534398793"